Edonentan anhydrous

DB21170ExperimentalSmall molecule

Edonentan anhydrous is a small molecule drug. The usage of the INN stem '-entan' in the name indicates that Edonentan anhydrous is a endothelin receptor antagonist. Edonentan anhydrous has a... Edonentan anhydrous has a monoisotopic molecular weight of 536.21 Da.

Mechanism: Pharmacologically active on Endothelin-1 receptor
Curator reviewed
Formula / weight: C₂₈H₃₂N₄O₅S · 536.65 g/mol (avg)
Also known as: Edonentan
Code names: BMS-207940

Resolves to

Compound

UNIIS5016F5ZH4CAS210891-04-6ChEMBLCHEMBL383581

Structure

InChIKeyORJRYNKVKJAJPY-UHFFFAOYSA-NSMILESCN(CC1=CC(=CC=C1C1=C(C=CC=C1)S(=O)(=O)NC1=NOC(C)=C1C)C1=NC=CO1)C(=O)CC(C)(C)C

Targets

P25101EDNRAP24530EDNRB

What you can answer from here — as of September 16, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Edonentan anhydrous, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account